Buparvax

For the treatment of tick-transmitted theileriosis caused by intracellular protozoan parasites Theileria parva (East Coast fever, Corridor disease, Zimbabwean theileriosis) and T. annulata (tropical theileriosis) in cattle. It is active against the schizont and piroplasm stages of Theileria spp. And may be used during the incubation period of the disease, or when clinical signs are apparent.

Category:

Buparvaquone is a second generation hydroxynaphtaquinone with features that make it an effective compound for the therapy and prophylaxis of all forms of theileriosis. It exerts its action on the parasites mitochodrion electron transport i.e directly inhibiting respiratory system of theileria parasites.

INDICATIONS

For the treatment of tick-transmitted theileriosis caused by intracellular protozoan parasites Theileria parva (East Coast fever, Corridor disease, Zimbabwean theileriosis) and T. annulata (tropical theileriosis) in cattle. It is active against the schizont and piroplasm stages of Theileria spp. And may be used during the incubation period of the disease, or when clinical signs are apparent.

CONTRA INDICATIONS

Due to the inhibiting effects of theileriosis on the immune system, vaccination should be delayed until the animal has recovered from theileriosis.

WITHDRAWAL TIMES
  • Meat: 42 day.
  • Milk: 2 days
STORAGE CONDITIONS
  • Store below 30°C in a dry place away from direct sunlight.
  • Keep out of reach of children.
PACK SIZES

20 ml and 50 ml vials